Initial Antihypertensive Prescription and Switching: A 5 Year Cohort Study from 250,851 Patients

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wong, Martin C S ^a   Tam, Wilson W S ^a   Cheung, Clement S K ^b   Tong, Ellen L H ^b   Sek, Antonio C H ^b   John, George ^c   Cheung, N T ^b   Yan, Bryan P Y ^a   Yu, C M ^a   Leeder, Stephen ^d   Griffiths, Sian ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b Hospital Authority Information Technology Services   (Hong Kong)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRESCRIPTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRESCRIPTION DRUGS;

EID: 84872285881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053625     Document Type: Article

References (43)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J, (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004 22: 11-19.
2. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, (2002) Selected major risk factors and global and regional burden of disease. Lancet 2002 360: 1347-1360.
3. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, et al. (2004) The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 44: 398-404.
4. Hajjar I, Kotchen TA, (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 290: 199-206.
5. Meng XJ, Dong GH, Wang D, Liu MM, Liu YQ, et al. (2012) Epidemiology of Prehypertension and Associated Risk Factors in Urban Adults From 33 Communities in China - The CHPSNE Study - Circ J 2012 doi: 10.1253/circj.CJ-11-1118.
6. Kim SJ, Lee J, Nam CM, Jee SH, Park IS, et al. (2011) Progression rate from new-onset pre-hypertension to hypertension in Korean adults. Circ J 2011 75: 135-140.
7. Kokubo Y, Kamide K, (2009) High-normal blood pressure and the risk of cardiovascular disease. Circ J 73: 1381-1385.
8. Tseng CH, Chong CK, Tseng CP, Shau WY, Tai TY, (2008) Hypertension is the most important component of metabolic syndrome in the association with ischemic heart disease in Taiwanese type 2 diabetic patients. Circ J. 72: 1419-24.
9. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet. 365: 217-223.
10. Kannel WB, (1996) Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 275: 1571-1576.
11. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL, (2007) Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 49: 69-75.
12. Li H, Meng Q, Sun X, Salter A, Briggs NE, et al. (2010) Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens. 28: 432-8.
13. Meng XJ, Dong GH, Wang D, Liu MM, Lin Q, et al. (2011) Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens. 29: 1303-10.
14. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, et al. (2011) American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association. Circulation. 2011 123: 933-44.
15. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, et al. (1997) Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials - the INDANA investigators. Ann Intern Med. 126: 761-767.
16. Chou CC, Lee MS, Ke CH, Chuang MH, (2005) Factors influencing the switch in the use of antihypertensive medications. Int J Clin Pract. 59: 85-91.
17. Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, et al. (2008) Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 26: 819-824.
18. Mazzaglia G, Mantovani L, Sturkenboom MC, Filippi A, Trifirò G, et al. (2005) Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 23: 2093-2100.
19. Erkens JA, Panneman MMJ, Klungel OH, van den Boom G, Prescott MF, et al. (2005) Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf. 14: 795-803.
20. Brown MJ, (2006) Hypertension and ethnic group. BMJ 332: 833-836.
21. Wong MCS, Wang HHX, Jiang JY, Leeder S, Griffiths SM, (2011) Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong. Asia Pacific Family Medicine 10: 10.
22. Wong MCS, Su XF, Jiang JY, Tang JL, Griffiths SM (2011) Profiles of Discontinuation and Switching of Thiazide Diuretics: a Cohort Study among 9,398 Chinese Hypertensive Patients. Hypertens Res doi: 10.1038/hr.2011.43.
23. Wong MCS, Jiang Y, Griffiths S, (2010) Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study. J Hum Hypertens. 24: 669-77.
24. Wong MC, Jiang JY, Griffiths SM, (2009) Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens. 22: 904-10.
25. Cheung NT Health informatics, Hospital Authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. Available: http://www.ehealth.org.hk/Speaker/Dr%20Ngai%20Tseung%20CHEUNG.pdf. Accessed: 2012 July 19.
26. Wong MCS, Jiang JY, Tang JL, Lam A, Fung H, et al. (2008) Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res 2008 8: 138.
27. Population by-census, 2006, Hong Kong Special Administrative Region, China. Available: http://www.bycensus2006.gov.hk/data/data2/index.htm. Accessed 2012 July 19.
28. Census and Statistics Department. The Government of the Hong Kong Administrative Region. Available: http://www.censtatd.gov.hk/hong_kong_statistics/statistics_by_subject/index.jsp?subjectID=1&charsetID=1&displayMode=T. Accessed 2012 July 19.
29. Burke TA, Sturkenboom MC, Lu S, Wenworth CE, Lin Y, et al. (2006) Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 24: 1193-1200.
30. Nicotra F, Wettermark B, Sturkenboom MC, Parodi A, Bellocco R, et al. (2009) Management of antihypertensive drugs in three European countries. J Hypertens. 27: 1917-1922.
31. Wong MC, Jiang JY, Lam AT, Fung H, Griffiths S, et al. (2008) Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens. 22: 714-6.
32. Shafi T, Appel LJ, Miller ER 3rd, Klag MJ, Parekh RS (2008) Changes in serum potassium mediate thiazide-induced diabetes. Hypertension 52: 1022-9.
33. National Collaborating Centre for Chronic Conditions (2006) Hypertension: management in adults in primary care: pharmacological update. London: Royal College of Physicians.
34. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC-7 report. JAMA. 289: 2560-2572.
35. Hong Kong Reference Framework for Hypertension Care for Adults in Primary Care Settings (2010) The Hong Kong Government. Available: http://www.fhb.gov.hk/download/press_and_publications/otherinfo/101231_primary_care/e_hypertension_care.pdf. Accessed 2012 July 19.
36. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD, (1999) Persistence with treatment for hypertension in actual practice. CMAJ. 160: 31-7.
37. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, et al. (2002) A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002 24: 1347-1357.
38. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, et al. (1999) Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. Am J Hypertens. 12: 374-80.
39. Billups SJ, Malone DC, Carter BL, (2000) The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy. 20: 941-49.
40. Flack JM, Novikov SV, Ferrario CM, (1996) Benefits of adherence to antihypertensive drug therapy. Eur Heart J. 17: 16-20.
41. Chan L, Tsui PN, Ng YS, Chan CH, Suen HN, et al. (2007) Management of Hypertension in General Out Patient Clinics (GOPCs) of New Territories West Cluster: Yesterday, Today and Tomorrow. HK Pract. 29: 470-480.
42. Benetos A, Thomas F, Bean KE, Guize L, (2003) Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens. 21: 1635-1640.
43. Redon J, Cea-Calvo L, Lozano JV, Martí-Canales JC, Llisterri JL, et al. (2007) PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain: the Prevention de Riesgo de Ictus (PREV-ICTUS) study. Hypertension. 49: 799-805.